Retraction

Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway

Paper Information

Record ID:
45402
Publication Date:
September 28, 2017
Retraction Date:
March 17, 2023 (2.7 years years ago)
Article Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.3892/mmr.2023.12978
Additional Notes:

see also: https://pubpeer.com/publications/0B8828E324C3E1E984A5D368931CD2

Citations (13)

13
Total Citations
2
Post-Retraction
(15.4%)
11
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
180 Days since retraction (latest)
Zinc Oxide Nanoparticles (ZnO NPs) Treated Two Types of Osteosarcoma Cell Lines for Identifying Differentially Expressed Genes
Xiangfei Guo, Linbang Wang, Honghao Yang et al. (4 authors)
Research Square (Research Square) Open Access
Published: Sep 2023
180 days after retraction
Identification of Differentially Expressed Genes in two Types of Osteosarcoma cell lines upon Zinc Oxide Nanoparticles Treatment Using the RNA-seq Technique
Guanping He, Xiangfei Guo, Linbang Wang et al. (4 authors)
Research Square (Research Square) Open Access
Published: Apr 2023
32 days after retraction
The roles of glycolysis in osteosarcoma
Zuxi Feng, Yanghuan Ou, Liang Hao
Frontiers in Pharmacology Open Access
Published: Aug 2022
35 citations
212 days before retraction
The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies
Jie Xu, Lin Li, Pengfei Shi et al. (5 authors)
International Journal of Molecular Sciences Open Access
Published: Jul 2022
33 citations
234 days before retraction
BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1
Qiang Wang, Yinghui Wu, Meng Lin et al. (9 authors)
Cancer Cell International Open Access
Published: Mar 2022
30 citations
355 days before retraction
miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma
Kentaro Sato, Eiji Osaka, Kyoko Fujiwara et al. (7 authors)
Oncology Reports Open Access
Published: Mar 2022
8 citations
367 days before retraction
Osteosarcoma and Metastasis
Gaohong Sheng, Yuan Gao, Yang Yong et al. (4 authors)
Frontiers in Oncology Open Access
Published: Dec 2021
135 citations
462 days before retraction
Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms
Mohammad Tobeiha, Ali Rajabi, Arash Raisi et al. (10 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Oct 2021
32 citations
511 days before retraction
miR-135a Reduces Osteosarcoma Pulmonary Metastasis by Targeting Both BMI1 and KLF4
Chenglong Chen, Xingjia Mao, Caitong Cheng et al. (10 authors)
Frontiers in Oncology Open Access
Published: Mar 2021
23 citations
725 days before retraction
Resveratrol inhibits cell growth via targeting the Bmi-1 pathway in YD-10B human oral squamous cell carcinoma cells
Kyoung-Eun Park, Chang Youp Ok, Hye‐Ock Jang et al. (5 authors)
International Journal of Oral Biology Open Access
Published: Sep 2020
898 days before retraction
Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells
Xi Jiang, Yulin Huang
Medical Science Monitor Open Access
Published: Jul 2020
17 citations
963 days before retraction
Potential Research Tool of Stem Cells from Human Exfoliated Deciduous Teeth: Lentiviral Bmi-1 Immortalization with EGFP Marker
Siqi Yao, Lingping Tan, Huan Chen et al. (6 authors)
Stem Cells International Open Access
Published: Mar 2019
5 citations
1468 days before retraction
Angiogenesis Process in Osteosarcoma: An Updated Perspective of Pathophysiology and Therapeutics
Yusheng Li, Qing Liu, Jian Tian et al. (5 authors)
The American Journal of the Medical Sciences
Published: Dec 2018
32 citations
1555 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 2.7 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
miR-129-2-3p inhibits colon cancer cell proliferation by do…
Arab Journal of Gastroenterology • 12 citations
AKR1C1 alleviates LPS-induced ALI in mice by activating the…
Molecular Medicine Reports • 13 citations
Tan IIA inhibits H1299 cell viability through the MDM4-IAP3…
Molecular Medicine Reports • 17 citations
Tanshinone IIA improves hypoxic ischemic encephalopathy thr…
Molecular Medicine Reports • 26 citations